Post-diagnostic multivitamin supplement use and colorectal cancer survival: a prospective cohort study

Background: Use of multivitamin supplements has been associated with lower incidence of colorectal cancer (CRC). However, its influence on CRC survival remains unknown. Methods: Among 2424 patients with stage I-III CRC who provided detailed information about multivitamin supplements in the Nurses’ H...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: He, Ming-ming (VerfasserIn) , Wang, Kai (VerfasserIn) , Lo, Chun-Han (VerfasserIn) , Zhang, Yiwen (VerfasserIn) , Polychronidis, Georgios (VerfasserIn) , Knudsen, Markus D. (VerfasserIn) , Zhong, Rong (VerfasserIn) , Ma, Yuan (VerfasserIn) , Wu, Kana (VerfasserIn) , Chan, Andrew T. (VerfasserIn) , Giovannucci, Edward L. (VerfasserIn) , Ogino, Shuji (VerfasserIn) , Ng, Kimmie (VerfasserIn) , Meyerhardt, Jeffrey A. (VerfasserIn) , Song, Mingyang (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 June 2024
In: Cancer
Year: 2024, Jahrgang: 130, Heft: 12, Pages: 2169-2179
ISSN:1097-0142
DOI:10.1002/cncr.35234
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cncr.35234
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.35234
Volltext
Verfasserangaben:Ming‐ming He MD, Kai Wang MD, PhD, Chun‐Han Lo MD, MPH, Yiwen Zhang PhD, Georgios Polychronidis MD, Markus D. Knudsen PhD, Rong Zhong PhD, Yuan Ma PhD, Kana Wu MD, PhD, Andrew T. Chan MD, MPH, Edward L. Giovannucci MD, ScD, Shuji Ogino MD, PhD, Kimmie Ng MD, MPH, Jeffrey A. Meyerhardt MD, MPH, Mingyang Song MD, ScD

MARC

LEADER 00000caa a2200000 c 4500
001 1892399784
003 DE-627
005 20241205144920.0
007 cr uuu---uuuuu
008 240628s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/cncr.35234  |2 doi 
035 |a (DE-627)1892399784 
035 |a (DE-599)KXP1892399784 
035 |a (OCoLC)1475300989 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a He, Ming-ming  |e VerfasserIn  |0 (DE-588)1330859081  |0 (DE-627)1889925632  |4 aut 
245 1 0 |a Post-diagnostic multivitamin supplement use and colorectal cancer survival  |b a prospective cohort study  |c Ming‐ming He MD, Kai Wang MD, PhD, Chun‐Han Lo MD, MPH, Yiwen Zhang PhD, Georgios Polychronidis MD, Markus D. Knudsen PhD, Rong Zhong PhD, Yuan Ma PhD, Kana Wu MD, PhD, Andrew T. Chan MD, MPH, Edward L. Giovannucci MD, ScD, Shuji Ogino MD, PhD, Kimmie Ng MD, MPH, Jeffrey A. Meyerhardt MD, MPH, Mingyang Song MD, ScD 
264 1 |c 15 June 2024 
300 |b Illustrationen 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Zuerst veröffentlicht: 06. Februar 2024 
500 |a Gesehen am 28.06.2024 
520 |a Background: Use of multivitamin supplements has been associated with lower incidence of colorectal cancer (CRC). However, its influence on CRC survival remains unknown. Methods: Among 2424 patients with stage I-III CRC who provided detailed information about multivitamin supplements in the Nurses’ Health Study and Health Professionals Follow-up Study, the authors calculated multivariable hazard ratios (HRs) of multivitamin supplements for all-cause and CRC-specific mortality according to post-diagnostic use and dose of multivitamin supplements. Results: During a median follow-up of 11 years, the authors documented 1512 deaths, among which 343 were of CRC. Compared to non-users, post-diagnostic users of multivitamin supplements at a dose of 3-5 tablets/week had lower CRC-specific mortality (HR, 0.55; 95% confidence interval [CI], 0.36-0.83, p = .005), and post-diagnostic users at doses of 3-5 and 6-9 tablets/week had lower all-cause mortality (HR, 0.81; 95% CI, 0.67-0.99, p = .04; HR, 0.79; 95% CI, 0.70-0.88), p < .001). The dose-response analysis showed a curvilinear relationship for both CRC-specific (pnonlinearity < .001) and all-cause mortality (pnonlinearity = .004), with the maximum risk reduction observed at 3-5 tablets/week and no further reduction at higher doses. Compared to non-users in both pre- and post-diagnosis periods, new post-diagnostic users at dose of <10 tablets/week had a lower all-cause mortality (HR, 0.81; 95% CI, 0.71-0.94, p = .005), whereas new users at a dose of ≥10 tablets/week (HR, 1.58; 95% CI, 1.07-2.33) and discontinued users (HR, 1.35; 95% CI, 1.14-1.59) had a higher risk of mortality. Conclusions: Use of multivitamin supplements at a moderate dose after a diagnosis of nonmetastatic CRC is associated with lower CRC-specific and overall mortality, whereas a high dose (≥10 tablets/week) use is associated with higher CRC-specific mortality. 
650 4 |a colorectal cancer 
650 4 |a mortality 
650 4 |a multivitamin 
650 4 |a nonmetastasis 
650 4 |a post-diagnosis 
650 4 |a survival 
700 1 |a Wang, Kai  |e VerfasserIn  |4 aut 
700 1 |a Lo, Chun-Han  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Yiwen  |e VerfasserIn  |4 aut 
700 1 |a Polychronidis, Georgios  |d 1984-  |e VerfasserIn  |0 (DE-588)1071576984  |0 (DE-627)826052975  |0 (DE-576)433162384  |4 aut 
700 1 |a Knudsen, Markus D.  |e VerfasserIn  |4 aut 
700 1 |a Zhong, Rong  |e VerfasserIn  |4 aut 
700 1 |a Ma, Yuan  |e VerfasserIn  |4 aut 
700 1 |a Wu, Kana  |e VerfasserIn  |4 aut 
700 1 |a Chan, Andrew T.  |e VerfasserIn  |4 aut 
700 1 |a Giovannucci, Edward L.  |e VerfasserIn  |4 aut 
700 1 |a Ogino, Shuji  |e VerfasserIn  |4 aut 
700 1 |a Ng, Kimmie  |e VerfasserIn  |4 aut 
700 1 |a Meyerhardt, Jeffrey A.  |e VerfasserIn  |4 aut 
700 1 |a Song, Mingyang  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancer  |d New York, NY : Wiley-Liss, 1948  |g 130(2024), 12 vom: Juni, Seite 2169-2179  |h Online-Ressource  |w (DE-627)271350334  |w (DE-600)1479932-7  |w (DE-576)078590884  |x 1097-0142  |7 nnas  |a Post-diagnostic multivitamin supplement use and colorectal cancer survival a prospective cohort study 
773 1 8 |g volume:130  |g year:2024  |g number:12  |g month:06  |g pages:2169-2179  |g extent:11  |a Post-diagnostic multivitamin supplement use and colorectal cancer survival a prospective cohort study 
856 4 0 |u https://doi.org/10.1002/cncr.35234  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.35234  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240628 
993 |a Article 
994 |a 2024 
998 |g 1071576984  |a Polychronidis, Georgios  |m 1071576984:Polychronidis, Georgios  |d 910000  |d 910200  |e 910000PP1071576984  |e 910200PP1071576984  |k 0/910000/  |k 1/910000/910200/  |p 5 
999 |a KXP-PPN1892399784  |e 4543006917 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Zuerst veröffentlicht: 06. Februar 2024","Gesehen am 28.06.2024"],"recId":"1892399784","name":{"displayForm":["Ming‐ming He MD, Kai Wang MD, PhD, Chun‐Han Lo MD, MPH, Yiwen Zhang PhD, Georgios Polychronidis MD, Markus D. Knudsen PhD, Rong Zhong PhD, Yuan Ma PhD, Kana Wu MD, PhD, Andrew T. Chan MD, MPH, Edward L. Giovannucci MD, ScD, Shuji Ogino MD, PhD, Kimmie Ng MD, MPH, Jeffrey A. Meyerhardt MD, MPH, Mingyang Song MD, ScD"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"15 June 2024"}],"language":["eng"],"id":{"eki":["1892399784"],"doi":["10.1002/cncr.35234"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"id":{"eki":["271350334"],"doi":["10.1002/(ISSN)1097-0142"],"zdb":["1479932-7"],"issn":["1097-0142"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedKey":"1948","publisher":"Wiley-Liss","dateIssuedDisp":"1948-","publisherPlace":"New York, NY"}],"part":{"volume":"130","text":"130(2024), 12 vom: Juni, Seite 2169-2179","pages":"2169-2179","extent":"11","year":"2024","issue":"12"},"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"Cancer cytopathology"}],"title":[{"title_sort":"Cancer","title":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society"}],"disp":"Post-diagnostic multivitamin supplement use and colorectal cancer survival a prospective cohort studyCancer","pubHistory":["1.1948 -"],"recId":"271350334","note":["Gesehen am 06.12.2011"]}],"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen"}],"person":[{"display":"He, Ming-ming","family":"He","given":"Ming-ming","role":"aut"},{"role":"aut","given":"Kai","family":"Wang","display":"Wang, Kai"},{"given":"Chun-Han","family":"Lo","display":"Lo, Chun-Han","role":"aut"},{"role":"aut","display":"Zhang, Yiwen","family":"Zhang","given":"Yiwen"},{"given":"Georgios","family":"Polychronidis","display":"Polychronidis, Georgios","role":"aut"},{"role":"aut","given":"Markus D.","display":"Knudsen, Markus D.","family":"Knudsen"},{"role":"aut","family":"Zhong","display":"Zhong, Rong","given":"Rong"},{"given":"Yuan","display":"Ma, Yuan","family":"Ma","role":"aut"},{"role":"aut","given":"Kana","family":"Wu","display":"Wu, Kana"},{"role":"aut","given":"Andrew T.","family":"Chan","display":"Chan, Andrew T."},{"family":"Giovannucci","display":"Giovannucci, Edward L.","given":"Edward L.","role":"aut"},{"given":"Shuji","family":"Ogino","display":"Ogino, Shuji","role":"aut"},{"role":"aut","display":"Ng, Kimmie","family":"Ng","given":"Kimmie"},{"display":"Meyerhardt, Jeffrey A.","family":"Meyerhardt","given":"Jeffrey A.","role":"aut"},{"role":"aut","display":"Song, Mingyang","family":"Song","given":"Mingyang"}],"title":[{"title":"Post-diagnostic multivitamin supplement use and colorectal cancer survival","subtitle":"a prospective cohort study","title_sort":"Post-diagnostic multivitamin supplement use and colorectal cancer survival"}]} 
SRT |a HEMINGMINGPOSTDIAGNO1520